Cellares

South San Francisco, CA · Founded 2019 · Privately Held (backing)

Operator of an integrated development and manufacturing organization intended for accelerating patients' access to life-saving cell therapies. Cellares is based in South San Francisco, CA and was founded in 2019. It is valued at about $675 million as of Oct 2026, set by institutional fund marks. It has raised $612 million across 1 recorded round; the latest was an $82 million later-stage round in Apr 2021.

PMV mark · valuation
$675.0M
Oct 2026
Priced at
its later-stage round
Aug 2023
Total raised
$612.0M
Last round
Later Stage VC
Apr 2021

Who backs Cellares?

16 investors
InvestorType
8VCVenture capital
EDBIVenture capital
Baillie GiffordGrowth equity
T. Rowe Price Group—
Eclipse CapitalHedge fund
Koch Disruptive TechnologiesVenture capital
DFJ GrowthVenture capital
Bristol-Myers Squibb—
EcoR1 CapitalHedge fund
Gates FrontierOther
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cellares investors

16 investors are on record for Cellares, including 8VC, EDBI, Baillie Gifford and T. Rowe Price Group. By type, the record holds 4 venture capital firms, 2 family offices and 2 hedge funds. The later-stage round in Apr 2021 drew 9 investors.

Free account
More of Cellares with a free account
  • ·The complete investor list: 16 names
  • ·Watch Cellares: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Cellares. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View